glp 1 stocks to buy today GLP-1 Agonists Market Report 2025-2033, By Product, Molecule, and Geo glp 1 stocks to buy
Description
Do GLP-1 drugs reduce cancer risk beyond weight loss
Glucagon-like peptide-1 (GLP-1) is an incretin hormone released from gut enteroendocrine cells that modulates glucose metabolism by controlling insulin excretion and glucagon secretion and inhibits gastric emptying leading to decreased food intake, thus limiting weight gain
Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.
The cAMP-mediated PKA/extracellular signal-regulated kinase (ERK) pathway also contributes to the regulation of antioxidant enzymes, which in turn aids in the prevention of skin aging
